Written by Santosh Rao, MD Head and neck cancers, occurring in such a sensitive area of the body, can pose a number of issues for those undergoing treatment. The mainstays of curative treatment are surgery and/or radiation, both of which can...
Written by Geoffrey Neuner, MD It is an understatement to say head and neck cancer is a challenging disease for patients, caregivers and clinicians. Curative treatment consists of either surgery, radiation or both, often combined with cytotoxic chemotherapy. The individual treatments...
Written by Jessica McDermott, MD Introduction Anyone who currently has or who has survived head and neck squamous cell cancer (HNSCC) can tell you that the cancer itself and the treatment involved can cause significant pain. The location of the tumors as...
Richard C. Niemtzow, MD, PhD, MPH Xerostomia Xerostomia or dry mouth is caused by a disturbance of the salivary glands. This is especially prevalent among head and neck oncology patients who have experienced chemotherapy, radiation and surgery for their head and neck...
Dan Zandberg, MD Introduction Currently, two immunotherapy medications, Nivolumab (Opdivo) and Pembrolizumab (Keytruda) are approved in the USA for recurrent and or metastatic squamous cell carcinoma of head and neck (HNSCC) after a patient received and failed “platinum” based chemotherapy. Both Nivolumab...
